PMC:7102591 / 10708-10905 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"336","span":{"begin":181,"end":183},"obj":"Gene"},{"id":"347","span":{"begin":33,"end":43},"obj":"Disease"},{"id":"348","span":{"begin":121,"end":130},"obj":"Disease"}],"attributes":[{"id":"A336","pred":"tao:has_database_id","subj":"336","obj":"Gene:1431"},{"id":"A347","pred":"tao:has_database_id","subj":"347","obj":"MESH:D007239"},{"id":"A348","pred":"tao:has_database_id","subj":"348","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"adverse events, including severe infections and the high risk of developing comorbidities further increasing the risk of infection [27,38]. Although RCTs conducted in the past with CS showed no hig"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T51","span":{"begin":181,"end":183},"obj":"Body_part"}],"attributes":[{"id":"A51","pred":"fma_id","subj":"T51","obj":"http://purl.org/sig/ont/fma/fma284995"}],"text":"adverse events, including severe infections and the high risk of developing comorbidities further increasing the risk of infection [27,38]. Although RCTs conducted in the past with CS showed no hig"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T146","span":{"begin":33,"end":43},"obj":"Disease"},{"id":"T147","span":{"begin":121,"end":130},"obj":"Disease"}],"attributes":[{"id":"A146","pred":"mondo_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A147","pred":"mondo_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"adverse events, including severe infections and the high risk of developing comorbidities further increasing the risk of infection [27,38]. Although RCTs conducted in the past with CS showed no hig"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T78","span":{"begin":181,"end":183},"obj":"Chemical"}],"attributes":[{"id":"A78","pred":"chebi_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/CHEBI_73462"},{"id":"A79","pred":"chebi_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"adverse events, including severe infections and the high risk of developing comorbidities further increasing the risk of infection [27,38]. Although RCTs conducted in the past with CS showed no hig"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T53","span":{"begin":26,"end":43},"obj":"Phenotype"}],"attributes":[{"id":"A53","pred":"hp_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/HP_0032169"}],"text":"adverse events, including severe infections and the high risk of developing comorbidities further increasing the risk of infection [27,38]. Although RCTs conducted in the past with CS showed no hig"}

{"project":"2_test","denotations":[{"id":"32205186-23192911-4826884","span":{"begin":132,"end":134},"obj":"23192911"},{"id":"32205186-17870034-4826885","span":{"begin":135,"end":137},"obj":"17870034"}],"text":"adverse events, including severe infections and the high risk of developing comorbidities further increasing the risk of infection [27,38]. Although RCTs conducted in the past with CS showed no hig"}